搜索临床试验以:breast density
总计28178个结果
-
Kyoto Breast Cancer Research NetworkPfizer完全的
-
Novartis Pharmaceuticals完全的
-
Regina Elena Cancer InstituteFondazione Policlinico Universitario Agostino Gemelli IRCCS; University of Palermo; Federico II... 和其他合作者主动,不招人
-
Tomsk National Research Medical Center of the Russian...完全的
-
University of ManchesterUniversity of Nottingham; Queen Mary University of London; Manchester University NHS Foundation... 和其他合作者完全的
-
European Organisation for Research and Treatment...Sanofi; Novartis; Roche Pharma AG; Breast International Group; Agendia完全的
-
UMC UtrechtBayer; Maastricht University Medical Center; Amsterdam UMC, location VUmc; The Netherlands Cancer... 和其他合作者主动,不招人
-
University of California, IrvineUniversity of California, San Francisco; Beckman Laser Institute University of California Irvine撤销
-
SOLTI Breast Cancer Research Group终止
-
Dana-Farber Cancer InstitutePfizer完全的
-
The Netherlands Cancer InstituteGenentech, Inc.; EurocanPlatform; Rather完全的
-
Nalagenetics Pte LtdIndonesia University; SJH Initiatives; MRCCC Siloam Hospitals Semanggi主动,不招人
-
GOG FoundationNational Cancer Institute (NCI)完全的葡萄胎 | 绒癌 | FIGO I期妊娠滋养细胞肿瘤 | FIGO II期妊娠滋养细胞肿瘤 | FIGO III期妊娠滋养细胞肿瘤美国, 大韩民国, 加拿大, 日本, 英国
-
Novartis Pharmaceuticals终止晚期或转移性 ER+ 乳腺癌美国, 法国, 德国, 新加坡, 意大利, 日本, 比利时
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)终止
-
Memorial Sloan Kettering Cancer Center完全的
-
University of LeedsUniversity of Sheffield终止
-
Sentara Norfolk General HospitalGeorge Mason University; Dorothy G. Hoefer Foundation完全的
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG Oncology; NCIC Clinical Trials Group; Cancer and Leukemia Group...完全的
-
National Cancer Institute, NaplesUnity Health Toronto; University of Catania主动,不招人
-
University of Maryland, BaltimoreSyndax Pharmaceuticals终止I期乳腺癌 | II期乳腺癌 | IIIA期乳腺癌 | 三阴性乳腺癌 | 雌激素受体阴性乳腺癌 | 孕激素受体阴性乳腺癌 | HER2 阴性乳腺癌美国
-
Brigham and Women's HospitalNational Cancer Institute (NCI)主动,不招人
-
Emory UniversityNovartis终止IV 期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IIIC期乳腺癌 | 复发性乳腺癌 | 雌激素受体阳性乳腺癌 | 孕激素受体阳性乳腺癌 | HER2 阴性乳腺癌美国
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)主动,不招人
-
University of California, San FranciscoDana-Farber Cancer Institute; Translational Breast Cancer Research Consortium完全的
-
Instituto de Nutrición y Tecnología de los AlimentosPontificia Universidad Catolica de Chile; Servicio de Salud Metropolitano Sur Oriente主动,不招人
-
Astellas Pharma Global Development, Inc.Pfizer完全的